Stockreport

Ozempic copies for $14 as the generic GLP-1 era starts in India [Los Angeles Times (CA)]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Friday, crashing prices in the country with the third-largest overweight population. Natco Pharma Ltd. plans to make an injection for semaglutide — the active ingredie [Read more]